{"id":454376,"date":"2026-07-18T15:49:00","date_gmt":"2026-07-18T07:49:00","guid":{"rendered":"https:\/\/pingtungtimes.com.tw\/?p=454376"},"modified":"2026-07-18T15:49:00","modified_gmt":"2026-07-18T07:49:00","slug":"dimerix%e6%94%b6%e8%b3%bc%e4%b8%80%e6%ac%be%e5%b7%b2%e5%85%b7%e5%82%992%e6%9c%9f%e8%87%a8%e5%ba%8a%e5%95%9f%e5%8b%95%e6%a2%9d%e4%bb%b6%e7%9a%84%e6%80%a5%e6%80%a7%e8%85%8e%e6%90%8d%e5%82%b7%e5%80%99","status":"publish","type":"post","link":"https:\/\/pingtungtimes.com.tw\/?p=454376","title":{"rendered":"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda"},"content":{"rendered":"<div>\n<p><b>\u8981\u9ede<\/b><\/p>\n<ul type=\"disc\">\n<li>Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI)<\/li>\n<li>DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 &#8212; 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b<sup>[1]<\/sup>\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8<\/li>\n<li>\u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0&#8212; \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6<\/li>\n<li>\u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236<\/li>\n<li>DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7<\/li>\n<li>\u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853<\/li>\n<li>Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\">\u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c<\/span><span class=\"legendSpanClass\">2026\u5e747\u670818\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31<span>\u300c<\/span>Dimerix<span>\u300d<\/span>\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31<span>\u300c<\/span>Mission<span>\u300d<\/span>\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002<\/p>\n<p><b>\u95dc\u65bc<\/b><b>DMX-652 &#8212; \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d<\/b><\/p>\n<p>DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002<\/p>\n<p>\u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002<\/p>\n<p>DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002<\/p>\n<p><b>\u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda<\/b><\/p>\n<p>DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002<\/p>\n<p>\u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002<\/p>\n<p><span>\u300c<\/span>\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002<span>\u300d<\/span><\/p>\n<p><i>&#8211;\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb<\/i><\/p>\n<p><span>\u300c<\/span>DMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002<span>\u300d<\/span><\/p>\n<p><i>&#8212; Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb<\/i><\/p>\n<p><span>\u300c<\/span>DMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002<span>\u300d<\/span><\/p>\n<p><i>&#8212; Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb<\/i><\/p>\n<p><b>\u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7<\/b><\/p>\n<p>\u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c<sup>[2]<\/sup>\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002<sup>[1]<\/sup><\/p>\n<p>\u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002<\/p>\n<p><b>\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7<\/b><b>2\u671f\u81e8\u5e8a\u8a66\u9a57<\/b><\/p>\n<p>\u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002<\/p>\n<p>\u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002<sup>[3]<\/sup><\/p>\n<p><b>\u5c08\u5229\u4fdd\u8b77<\/b><\/p>\n<p>\u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\/EP2021\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\/GB2016\/050851\u3001PCT\/GB2019\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002<\/p>\n<p><b>\u5354\u8b70\u689d\u6b3e<\/b><\/p>\n<p>\u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002<\/p>\n<p><b>\u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6<\/b><\/p>\n<p>Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002<\/p>\n<p><b>\u8cc7\u91d1<\/b><\/p>\n<p>Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a<\/p>\n<ul type=\"disc\">\n<li>\u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b<\/li>\n<li>\u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b<sup>[1]<\/sup>\u4ee5\u53ca<\/li>\n<li>\u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002<\/li>\n<\/ul>\n<p>\u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002<sup>[4]<\/sup>,<sup>[5]<\/sup>\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002<\/p>\n<p class=\"prntar\"><i>\u7d93<\/i><i>Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002<\/i><\/p>\n<p>\u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1a<a href=\"https:\/\/www.dimerix.com\/\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">www.dimerix.com<\/a><\/p>\n<p>\u5728<a href=\"https:\/\/www.linkedin.com\/company\/dimerix-bioscience\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\"><b>LinkedIn<\/b><\/a>\u548c<a href=\"https:\/\/x.com\/dimerixltd\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\"><b>X<\/b><\/a>\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f<\/p>\n<p><b>\u95dc\u65bc<\/b><b>Dimerix<\/b><\/p>\n<p>Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002<\/p>\n<p><b>\u95dc\u65bc<\/b><b>Mission Therapeutics<\/b><\/p>\n<p>Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002<\/p>\n<p>Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002<\/p>\n<p><b>\u95dc\u65bc<\/b><b>DMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528<\/b><\/p>\n<p>DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a<sup>[6]<\/sup>\u3002<\/p>\n<p>FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002<sup>[7]<\/sup>\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c<sup>[8]<\/sup>\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002<\/p>\n<p><b>Dimerix\u524d\u77bb\u6027\u9673\u8ff0<\/b><\/p>\n<p>\u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><b>\u53c3\u8003\u6587\u737b<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[1]<\/sup><\/span><\/i>\u00a0<i>Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[2]<\/sup><\/span><\/i>\u00a0<i>Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[3]<\/sup><\/span><\/i>\u00a0\u00a0<i>Subject to recruitment<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[4]<\/sup><\/span><\/i>\u00a0\u00a0<i>Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent)<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[5]<\/sup><\/span><\/i>\u00a0\u00a0<i>Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[6]<\/sup><\/span><\/i>\u00a0\u00a0<i>ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[7]<\/sup><\/span><\/i>\u00a0\u00a0<i>Nephcure FSGS Facts (<\/i><i><a href=\"https:\/\/nephcure.org\/\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\" style=\"color: #0000FF\">https:\/\/nephcure.org\/<\/a><\/i><i>)<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><i><span class=\"prnews_span\"><sup>[8]<\/sup><\/span><\/i>\u00a0\u00a0<i>Front. Immunol., (July 2019) |<\/i>\u00a0<i><a href=\"https:\/\/doi.org\/10.3389\/fimmu.2019.01669\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\" style=\"color: #0000FF\">https:\/\/doi.org\/10.3389\/fimmu.2019.01669<\/a><\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u8981\u9ede Dimerix\u6536\u8cfc\u5df2\u5177\u5099&#8230;<\/p>\n","protected":false},"author":16,"featured_media":199219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[40567],"tags":[],"class_list":["post-454376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-40567"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831<\/title>\n<meta name=\"description\" content=\"\u8981\u9ede   Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI)  DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 -- 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8  \u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0-- \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6  \u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236  DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7  \u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853  Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7  \u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c2026\u5e747\u670818\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31\u300cDimerix\u300d\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31\u300cMission\u300d\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002 \u95dc\u65bcDMX-652 -- \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002 \u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002 DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002 \u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002 \u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002 \u300c\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002\u300d --\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb \u300cDMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002\u300d -- Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb \u300cDMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002\u300d -- Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb \u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 \u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002 \u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002 \u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b72\u671f\u81e8\u5e8a\u8a66\u9a57 \u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002 \u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002 \u5c08\u5229\u4fdd\u8b77 \u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\/EP2021\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\/GB2016\/050851\u3001PCT\/GB2019\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002 \u5354\u8b70\u689d\u6b3e \u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002 \u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6 Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002 \u8cc7\u91d1 Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a   \u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b  \u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b\u4ee5\u53ca  \u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002  \u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002,\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002 \u7d93Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002 \u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1awww.dimerix.com \u5728LinkedIn\u548cX\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f \u95dc\u65bcDimerix Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002 \u95dc\u65bcMission Therapeutics Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002 Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002 \u95dc\u65bcDMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528 DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u3002 FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002 Dimerix\u524d\u77bb\u6027\u9673\u8ff0 \u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002          \u53c3\u8003\u6587\u737b        \u00a0Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI        \u00a0Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7        \u00a0\u00a0Subject to recruitment        \u00a0\u00a0Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent)        \u00a0\u00a0Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company        \u00a0\u00a0ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025        \u00a0\u00a0Nephcure FSGS Facts (https:\/\/nephcure.org\/)        \u00a0\u00a0Front. Immunol., (July 2019) |\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.01669        \u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pingtungtimes.com.tw\/?p=454376\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"og:description\" content=\"\u8981\u9ede   Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI)  DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 -- 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8  \u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0-- \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6  \u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236  DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7  \u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853  Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7  \u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c2026\u5e747\u670818\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31\u300cDimerix\u300d\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31\u300cMission\u300d\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002 \u95dc\u65bcDMX-652 -- \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002 \u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002 DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002 \u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002 \u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002 \u300c\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002\u300d --\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb \u300cDMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002\u300d -- Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb \u300cDMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002\u300d -- Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb \u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 \u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002 \u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002 \u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b72\u671f\u81e8\u5e8a\u8a66\u9a57 \u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002 \u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002 \u5c08\u5229\u4fdd\u8b77 \u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\/EP2021\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\/GB2016\/050851\u3001PCT\/GB2019\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002 \u5354\u8b70\u689d\u6b3e \u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002 \u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6 Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002 \u8cc7\u91d1 Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a   \u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b  \u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b\u4ee5\u53ca  \u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002  \u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002,\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002 \u7d93Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002 \u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1awww.dimerix.com \u5728LinkedIn\u548cX\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f \u95dc\u65bcDimerix Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002 \u95dc\u65bcMission Therapeutics Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002 Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002 \u95dc\u65bcDMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528 DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u3002 FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002 Dimerix\u524d\u77bb\u6027\u9673\u8ff0 \u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002          \u53c3\u8003\u6587\u737b        \u00a0Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI        \u00a0Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7        \u00a0\u00a0Subject to recruitment        \u00a0\u00a0Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent)        \u00a0\u00a0Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company        \u00a0\u00a0ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025        \u00a0\u00a0Nephcure FSGS Facts (https:\/\/nephcure.org\/)        \u00a0\u00a0Front. Immunol., (July 2019) |\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.01669        \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pingtungtimes.com.tw\/?p=454376\" \/>\n<meta property=\"og:site_name\" content=\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pingtungnews\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-18T07:49:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"author\" content=\"\u7f8e\u901a\u793e\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u7f8e\u901a\u793e\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376\"},\"author\":{\"name\":\"\u7f8e\u901a\u793e\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\"},\"headline\":\"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda\",\"datePublished\":\"2026-07-18T07:49:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376\"},\"wordCount\":281,\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"articleSection\":[\"\u7f8e\u901a\u793e\"],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376\",\"name\":\"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"datePublished\":\"2026-07-18T07:49:00+00:00\",\"description\":\"\u8981\u9ede Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI) DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 -- 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8 \u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0-- \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6 \u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236 DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7 \u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853 Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7 \u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c2026\u5e747\u670818\u65e5 \\\/\u7f8e\u901a\u793e\\\/ -- \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31\u300cDimerix\u300d\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31\u300cMission\u300d\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002 \u95dc\u65bcDMX-652 -- \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002 \u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002 DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002 \u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002 \u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002 \u300c\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002\u300d --\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb \u300cDMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002\u300d -- Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb \u300cDMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002\u300d -- Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb \u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 \u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002 \u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002 \u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b72\u671f\u81e8\u5e8a\u8a66\u9a57 \u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002 \u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002 \u5c08\u5229\u4fdd\u8b77 \u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\\\/EP2021\\\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\\\/GB2016\\\/050851\u3001PCT\\\/GB2019\\\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002 \u5354\u8b70\u689d\u6b3e \u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002 \u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6 Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002 \u8cc7\u91d1 Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a \u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b \u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b\u4ee5\u53ca \u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002 \u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002,\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002 \u7d93Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002 \u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1awww.dimerix.com \u5728LinkedIn\u548cX\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f \u95dc\u65bcDimerix Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002 \u95dc\u65bcMission Therapeutics Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002 Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002 \u95dc\u65bcDMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528 DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u3002 FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002 Dimerix\u524d\u77bb\u6027\u9673\u8ff0 \u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002 \u53c3\u8003\u6587\u737b \u00a0Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI \u00a0Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\\\/\\\/doi.org\\\/10.1016\\\/s0140-6736(24)02385-7 \u00a0\u00a0Subject to recruitment \u00a0\u00a0Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent) \u00a0\u00a0Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company \u00a0\u00a0ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025 \u00a0\u00a0Nephcure FSGS Facts (https:\\\/\\\/nephcure.org\\\/) \u00a0\u00a0Front. Immunol., (July 2019) |\u00a0https:\\\/\\\/doi.org\\\/10.3389\\\/fimmu.2019.01669 \u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#primaryimage\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":\"3000\",\"height\":\"1990\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=454376#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"description\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4\",\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":150,\"height\":150,\"caption\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pingtungnews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\",\"name\":\"\u7f8e\u901a\u793e\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"caption\":\"\u7f8e\u901a\u793e\"},\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u8981\u9ede   Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI)  DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 -- 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8  \u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0-- \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6  \u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236  DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7  \u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853  Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7  \u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c2026\u5e747\u670818\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31\u300cDimerix\u300d\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31\u300cMission\u300d\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002 \u95dc\u65bcDMX-652 -- \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002 \u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002 DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002 \u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002 \u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002 \u300c\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002\u300d --\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb \u300cDMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002\u300d -- Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb \u300cDMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002\u300d -- Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb \u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 \u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002 \u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002 \u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b72\u671f\u81e8\u5e8a\u8a66\u9a57 \u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002 \u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002 \u5c08\u5229\u4fdd\u8b77 \u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\/EP2021\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\/GB2016\/050851\u3001PCT\/GB2019\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002 \u5354\u8b70\u689d\u6b3e \u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002 \u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6 Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002 \u8cc7\u91d1 Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a   \u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b  \u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b\u4ee5\u53ca  \u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002  \u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002,\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002 \u7d93Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002 \u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1awww.dimerix.com \u5728LinkedIn\u548cX\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f \u95dc\u65bcDimerix Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002 \u95dc\u65bcMission Therapeutics Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002 Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002 \u95dc\u65bcDMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528 DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u3002 FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002 Dimerix\u524d\u77bb\u6027\u9673\u8ff0 \u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002          \u53c3\u8003\u6587\u737b        \u00a0Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI        \u00a0Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7        \u00a0\u00a0Subject to recruitment        \u00a0\u00a0Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent)        \u00a0\u00a0Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company        \u00a0\u00a0ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025        \u00a0\u00a0Nephcure FSGS Facts (https:\/\/nephcure.org\/)        \u00a0\u00a0Front. Immunol., (July 2019) |\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.01669        \u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pingtungtimes.com.tw\/?p=454376","og_locale":"zh_TW","og_type":"article","og_title":"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","og_description":"\u8981\u9ede   Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI)  DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 -- 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8  \u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0-- \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6  \u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236  DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7  \u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853  Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7  \u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c2026\u5e747\u670818\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31\u300cDimerix\u300d\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31\u300cMission\u300d\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002 \u95dc\u65bcDMX-652 -- \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002 \u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002 DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002 \u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002 \u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002 \u300c\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002\u300d --\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb \u300cDMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002\u300d -- Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb \u300cDMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002\u300d -- Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb \u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 \u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002 \u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002 \u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b72\u671f\u81e8\u5e8a\u8a66\u9a57 \u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002 \u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002 \u5c08\u5229\u4fdd\u8b77 \u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\/EP2021\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\/GB2016\/050851\u3001PCT\/GB2019\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002 \u5354\u8b70\u689d\u6b3e \u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002 \u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6 Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002 \u8cc7\u91d1 Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a   \u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b  \u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b\u4ee5\u53ca  \u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002  \u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002,\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002 \u7d93Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002 \u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1awww.dimerix.com \u5728LinkedIn\u548cX\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f \u95dc\u65bcDimerix Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002 \u95dc\u65bcMission Therapeutics Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002 Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002 \u95dc\u65bcDMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528 DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u3002 FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002 Dimerix\u524d\u77bb\u6027\u9673\u8ff0 \u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002          \u53c3\u8003\u6587\u737b        \u00a0Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI        \u00a0Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7        \u00a0\u00a0Subject to recruitment        \u00a0\u00a0Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent)        \u00a0\u00a0Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company        \u00a0\u00a0ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025        \u00a0\u00a0Nephcure FSGS Facts (https:\/\/nephcure.org\/)        \u00a0\u00a0Front. Immunol., (July 2019) |\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.01669        \u00a0","og_url":"https:\/\/pingtungtimes.com.tw\/?p=454376","og_site_name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","article_publisher":"https:\/\/www.facebook.com\/pingtungnews","article_published_time":"2026-07-18T07:49:00+00:00","og_image":[{"url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","type":"","width":"","height":""}],"author":"\u7f8e\u901a\u793e","twitter_card":"summary_large_image","twitter_image":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","twitter_misc":{"\u4f5c\u8005:":"\u7f8e\u901a\u793e","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#article","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=454376"},"author":{"name":"\u7f8e\u901a\u793e","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3"},"headline":"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda","datePublished":"2026-07-18T07:49:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=454376"},"wordCount":281,"publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","articleSection":["\u7f8e\u901a\u793e"],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/pingtungtimes.com.tw\/?p=454376","url":"https:\/\/pingtungtimes.com.tw\/?p=454376","name":"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#primaryimage"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","datePublished":"2026-07-18T07:49:00+00:00","description":"\u8981\u9ede Dimerix\u6536\u8cfc\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u5019\u9078\u85e5\u7269DMX-652\uff0c\u8a72\u85e5\u7269\u6709\u671b\u4f9d\u6258\u4e00\u4efd\u5df2\u5728\u7f8e\u570b\u7372\u6279\u751f\u6548\u7684\u65b0\u85e5\u81e8\u5e8a\u8a66\u9a57(IND)\u7533\u8acb\uff0c\u5feb\u901f\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u521d\u671f\u9069\u61c9\u75c7\u805a\u7126\u6025\u6027\u814e\u640d\u50b7(AKI) DMX-652\u6709\u671b\u586b\u88dc\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u5de8\u5927\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42 -- 2026\u5e74\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u8a08\u905435\u5104\u7f8e\u5143\uff1b\u8a72\u75c5\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\uff0c\u6703\u5c0e\u81f4\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u4e14\u6b7b\u4ea1\u7387\u6975\u9ad8 \u5b89\u5168\u6027\u6578\u64da\u5145\u5206\u00a0-- \u4e00\u9805\u572885\u540d\u5065\u5eb7\u53d7\u8a66\u8005\u4e2d\u958b\u5c55\u7684\u5927\u578b1\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0cDMX-652\u55ae\u6b21\u7d66\u85e5\u53ca14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u8010\u53d7\u826f\u597d\uff0c\u672a\u51fa\u73fe\u8207\u53d7\u8a66\u85e5\u7269\u76f8\u95dc\u7684\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6 \u5df2\u53d6\u5f97\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u524d\u85e5\u6548\u6578\u64da\uff0c\u5145\u5206\u7684\u79d1\u5b78\u4f9d\u64da\u9a57\u8b49DMX-652\u4f5c\u7528\u6a5f\u5236 DMX-652\u70ba\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u5019\u9078\u85e5\u7269\uff0c\u76ee\u524d\u5df2\u77e5\u7121\u81e8\u5e8a\u968e\u6bb5\u7af6\u722d\u5c0d\u624b\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u6709\u671b\u64f4\u5c55\u81f3\u591a\u500b\u5176\u4ed6\u9069\u61c9\u75c7 \u8207\u6b63\u5728\u9032\u884c\u7684ACTION3 3\u671fFSGS\u7f55\u898b\u814e\u75c5\u9805\u76ee\u53caDimerix\u73fe\u6709\u66f4\u5ee3\u6cdb\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u9ad8\u5ea6\u6230\u7565\u5951\u5408\uff0c\u53ef\u5145\u5206\u5229\u7528Dimerix\u73fe\u6709\u57fa\u790e\u8a2d\u65bd\u8207\u5c08\u696d\u6280\u8853 Dimerix\u6838\u5fc3\u7ba1\u7dda\u7522\u54c1DMX-200\u7528\u65bcFSGS\uff08\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7\uff09\u7684ACTION3\u8a66\u9a57\u5df2\u5b8c\u6210\uff1b\u672c\u6b21DMX-652\u6536\u8cfc\u9996\u4ed8\u6b3e\u53ca2\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\u8cc7\u91d1\u5747\u5df2\u5230\u4f4d\uff08\u8a73\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\uff09\uff0c\u516c\u53f8\u540c\u6642\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u975e\u7a00\u91cb\u6027\u878d\u8cc7 \u6fb3\u5927\u5229\u4e9e\u58a8\u723e\u672c2026\u5e747\u670818\u65e5 \/\u7f8e\u901a\u793e\/ -- \u5c08\u6ce8\u65bc\u814e\u81df\u75c5\u6cbb\u7642\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8Dimerix Limited\uff08ASX: DXB\uff0c\u4e0b\u7a31\u300cDimerix\u300d\uff09\u6b23\u7136\u5ba3\u4f48\uff0c\u5df2\u5f9eMission Therapeutics Limited\uff08\u7c21\u7a31\u300cMission\u300d\uff09\u6536\u8cfcDMX-652\u7684\u5168\u90e8\u9069\u61c9\u75c7\u958b\u767c\u6b0a\u76ca\u3002\u8a72\u9805\u65b0\u8cc7\u7522\u9032\u4e00\u6b65\u8c50\u5bcc\u4e86Dimerix\u5728\u7f55\u898b\u814e\u75c5\u9818\u57df\u7684\u7814\u767c\u7ba1\u7dda\uff0c\u662f\u4e00\u7a2e\u65b0\u578b\u540c\u985e\u9996\u5275\u3001\u540c\u985e\u6700\u512a\u7684\u6cbb\u7642\u5019\u9078\u85e5\u7269\uff0c\u521d\u671f\u958b\u767c\u76ee\u6a19\u70ba\u6025\u6027\u814e\u640d\u50b7(AKI)\u7684\u9810\u9632\u3002 \u95dc\u65bcDMX-652 -- \u592f\u5be6Dimerix\u5728\u814e\u81df\u75c5\u9818\u57df\u7684\u9818\u5148\u5730\u4f4d DMX-652\u662f\u4e00\u7a2eUSP30\u9078\u64c7\u6027\u6291\u5236\u5291\uff0c\u800cUSP30\u662f\u4e00\u7a2e\u7dda\u7c92\u9ad4\u9176\uff0c\u6703\u5ef6\u7de9\u53d7\u640d\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\u9032\u7a0b\u3002DMX-652\u70ba\u53e3\u670d\u5c0f\u5206\u5b50\u5236\u5291\uff0c\u6bcf\u65e5\u50c5\u9700\u670d\u7528\u4e00\u7c92\u81a0\u56ca\uff0c\u53ef\u8abf\u63a7\u53d7\u640d\u814e\u81df\u7d30\u80de\u5167\u7dda\u7c92\u9ad4\u8cea\u91cf\u63a7\u5236\u3002\u8a72\u4f5c\u7528\u6a5f\u5236\u5df2\u88ab\u8b49\u5be6\u5728\u7f3a\u8840\uff08\u8840\u6d41\u4e0d\u8db3\u5c0e\u81f4\u7f3a\u6c27\uff09\u3001\u6bd2\u7d20\u6216\u81bf\u6bd2\u75c7\u76f8\u95dc\u539f\u56e0\u6240\u81f4\u7684AKI\u9032\u5c55\u4e2d\u767c\u63ee\u4f5c\u7528\uff0c\u4e5f\u53ef\u61c9\u7528\u65bc\u5176\u4ed6\u814e\u81df\u53ca\u975e\u814e\u81df\u9069\u61c9\u75c7\u3002 \u672c\u6b21DMX-652\u6536\u8cfc\u4ea4\u6613\u5305\u542b\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u8f49\u8b93\u3001\u7f8e\u570b\u5df2\u751f\u6548IND\uff08\u542b\u5df2\u7372\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u555f\u52d5\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u65b9\u6848\uff09\uff0c\u540c\u6642\u53d7\u8b93\u8db3\u91cf\u7b26\u5408\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4(GMP)\u7684\u8a66\u9a57\u7528\u85e5\u53ca\u5168\u5957\u751f\u7522\u5de5\u85dd\u3002\u672c\u6b212\u671f\u81e8\u5e8a\u8a66\u9a57\u65e8\u5728\u8a55\u4f30DMX-652\u9810\u9632\u814e\u640d\u50b7\u3001\u4fdd\u8b77\u814e\u529f\u80fd\u7684\u6f5b\u529b\uff0c\u800c\u5176\u7368\u7279\u4f5c\u7528\u6a5f\u5236\u672a\u4f86\u9084\u6709\u671b\u62d3\u5c55\u81f3\u5176\u4ed6\u9069\u61c9\u75c7\u3002 DMX-652\u76841\u671f\u81e8\u5e8a\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u5f8c\uff0c\u7f8e\u570bIND\u7533\u8acb\u6b63\u5f0f\u751f\u6548\uff0c2\u671f\u8a66\u9a57\u65b9\u6848\u7372\u6279\u30021\u671f\u8a66\u9a57\u517185\u540d\u5065\u5eb7\u5fd7\u9858\u8005\u63a5\u53d7\u4e86\u5019\u9078\u85e5\u7269\u6cbb\u7642\u3002\u8a66\u9a57\u6210\u529f\u8b49\u660e\uff1a\u6bcf\u65e5\u6700\u9ad8200\u6beb\u514b\u55ae\u6b21\u7d66\u85e5\u3001\u6bcf\u65e5\u6700\u9ad8100\u6beb\u514b\u9023\u7e8c14\u5929\u591a\u6b21\u7d66\u85e5\u5747\u5177\u5099\u826f\u597d\u5b89\u5168\u6027\u8207\u8010\u53d7\u6027\uff0c\u85e5\u4ee3\u52d5\u529b\u5b78\u8868\u73fe\u512a\u7570\u3002 \u6253\u9020\u805a\u7126\u7f55\u898b\u814e\u75c5\u7684\u7522\u54c1\u7ba1\u7dda DMX-652\u7684\u6536\u8cfc\u8207Dimerix\u7684\u6230\u7565\u9ad8\u5ea6\u5951\u5408\uff0c\u5373\u91dd\u5c0d\u91ab\u7642\u9700\u6c42\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u7f55\u898b\u814e\u75c5\u69cb\u5efa\u5c08\u9580\u4e14\u9ad8\u6548\u7684\u6cbb\u7642\u7ba1\u7dda\u3002DMX-652\u9805\u76ee\u662f\u516c\u53f8\u6838\u5fc3\u8cc7\u7522DMX-200\u7684\u88dc\u5145\uff0c\u5f8c\u8005\u7576\u524d\u6b63\u5728\u958b\u5c55\u91dd\u5c0d\u7f55\u898b\u814e\u75c5\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u7684\u95dc\u93753\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u53d7\u8a66\u8005\u5df2\u5168\u90e8\u5165\u7d44\u3002\u65b0\u589e\u4e92\u88dc\u7ba1\u7dda\u8cc7\u7522\uff0c\u80fd\u5920\u9032\u4e00\u6b65\u767c\u63eeDimerix\u5728\u814e\u75c5\u9818\u57df\u7684\u6838\u5fc3\u6280\u8853\u7a4d\u7d2f\u53ca\u73fe\u6709\u5168\u7403\u5408\u4f5c\u7db2\u7d61\u512a\u52e2\u3002 \u672c\u6b21\u6536\u8cfcDMX-652\u5c07Dimerix\u814e\u75c5\u6cbb\u7642\u4f48\u5c40\u5f9e\u814e\u5c0f\u7403\u75be\u75c5\u3001FSGS\u62d3\u5c55\u81f3\u6025\u6027\u814e\u640d\u50b7\u9818\u57df\u3002Dimerix\u7684\u814e\u81df\u75be\u75c5\u7814\u767c\u7ba1\u7dda\u73fe\u6db5\u84cb\u5169\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u9818\u57df\u7684\u5019\u9078\u85e5\u7269\uff0c\u5176\u4f5c\u7528\u6a5f\u5236\u5404\u5177\u7279\u8272\uff0c\u6709\u671b\u70ba\u60a3\u8005\u548c\u80a1\u6771\u5275\u9020\u53ef\u89c0\u50f9\u503c\u3002 \u300c\u6025\u6027\u814e\u640d\u50b7(AKI)\u4ecd\u7136\u662f\u5fc3\u81df\u624b\u8853\u5f8c\u6700\u5e38\u898b\u4e14\u6700\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u4e4b\u4e00\uff0c\u5927\u91cf\u60a3\u8005\u53d7\u5176\u56f0\u64fe\uff0c\u5c0e\u81f4\u767c\u75c5\u7387\u3001\u6b7b\u4ea1\u7387\u589e\u52a0\uff0c\u4f4f\u9662\u6642\u9593\u5ef6\u9577\uff0c\u4ee5\u53ca\u9577\u671f\u814e\u81df\u548c\u5fc3\u8840\u7ba1\u4f75\u767c\u75c7\u98a8\u96aa\u5347\u9ad8\u3002\u5118\u7ba1\u570d\u624b\u8853\u671f\u8b77\u7406\u4e0d\u65b7\u9032\u6b65\uff0c\u4f46\u76ee\u524d\u5c1a\u7121\u7372\u6279\u7684\u5c08\u9580\u7528\u65bc\u9810\u9632\u5fc3\u81df\u624b\u8853\u76f8\u95dcAKI\u7684\u7642\u6cd5\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u6211\u76f8\u4fe1DMX-652\u6709\u671b\u70ba\u63a5\u53d7\u5fc3\u81df\u624b\u8853\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6848\uff0c\u89e3\u6c7a\u9019\u4e00\u91cd\u5927\u81e8\u5e8a\u96e3\u984c\u3002\u300d --\u5fb7\u570b\u660e\u65af\u7279\u5927\u5b78\u91ab\u9662(University Hospital M\u00fcnster)\u9ebb\u9189\u79d1\u3001\u91cd\u75c7\u91ab\u5b78\u79d1\u53ca\u75bc\u75db\u79d1\u4e3b\u4efbAlexander Zarbock\u6559\u6388\u3001\u91ab\u5b78\u535a\u58eb \u300cDMX-652\u5728Mission Therapeutics\u8fc4\u4eca\u5b8c\u6210\u76841\u671f\u7814\u7a76\u4e2d\u7d66\u51fa\u4e86\u4ee4\u4eba\u4fe1\u670d\u7684\u81e8\u5e8a\u6578\u64da\u3002\u6025\u6027\u814e\u81df\u75be\u75c5\u5c0d\u65b0\u578b\u6709\u6548\u7642\u6cd5\u7684\u9700\u6c42\u5de8\u5927\uff0cDMX-652\u70ba\u9019\u4e9b\u60a3\u8005\u5e36\u4f86\u5168\u65b0\u7a81\u7834\u3002Dimerix\u6df1\u8015\u814e\u75c5\u8cfd\u9053\uff0c\u6210\u719f\u904b\u71df\u80fd\u529b\u6709\u76ee\u5171\u7779\uff0c\u662f\u63a8\u52d5\u9019\u6b3e\u91cd\u8981\u85e5\u7269\u7814\u767c\u8207\u5546\u696d\u5316\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\u3002\u300d -- Mission Therapeutics\u57f7\u884c\u8463\u4e8bAnker Lundemose\u535a\u58eb \u300cDMX-652\u662f\u4e00\u6b3e\u6a5f\u5236\u7368\u7279\u3001\u524d\u666f\u5ee3\u95ca\u7684\u5168\u65b0\u5316\u5408\u7269\uff0c\u6536\u8cfc\u9019\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u662f\u843d\u5be6\u64f4\u5145\u814e\u75c5\u7ba1\u7dda\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\u3002\u8a72\u8cc7\u7522\u8207\u6211\u5011\u6b63\u5728\u63a8\u9032\u7684FSGS 3\u671f\u9805\u76ee\u9ad8\u5ea6\u4e92\u88dc\uff0c\u5c07\u6211\u5011\u7684\u7814\u767c\u7248\u5716\u5f9e\u6025\u6027\u640d\u50b7\u5230\u6162\u6027\u75be\u75c5\uff0c\u8cab\u7a7f\u6574\u500b\u814e\u81df\u75be\u75c5\u8b5c\u7cfb\u3002\u300d -- Dimerix\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u8463\u4e8b\u7e3d\u7d93\u7406Nina Webster\u535a\u58eb \u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 \u6025\u6027\u814e\u640d\u50b7(AKI)\u662f\u767c\u75c5\u7387\u9ad8\u3001\u75c5\u60c5\u5371\u91cd\u7684\u81e8\u5e8a\u7d9c\u5408\u5f81\uff0c\u5b58\u5728\u5de8\u5927\u7684\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u3002\u9ad8\u767c\u65bc\u5fc3\u81df\u624b\u8853\u3001\u81bf\u6bd2\u75c7\u7b49\u9ad8\u98a8\u96aa\u81e8\u5e8a\u5834\u666f\uff0c\u5178\u578b\u7279\u5fb5\u70ba\u6578\u5c0f\u6642\u5167\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5e38\u4f34\u96a8\u9ad8\u81f4\u6b98\u7387\u8207\u6b7b\u4ea1\u7387\u3002\u7d93\u6e2c\u7b97\uff0c\u7f8e\u570b\u6bcf\u5e74\u7b26\u5408\u7528\u85e5\u6307\u5f81\u7684\u6f5b\u5728\u60a3\u8005\u7d0410\u842c\u81f313.3\u842c\u4eba\uff0c\u4f7f\u8a72\u9069\u61c9\u75c7\u53ef\u80fd\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u30022026\u5e74\u5168\u7403\u6025\u6027\u814e\u640d\u50b7\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d0435\u5104\u7f8e\u5143\uff0c\u9810\u8a08\u672a\u4f86\u5341\u5e74\u5c07\u589e\u9577\u81f375\u5104\u7f8e\u5143\u5de6\u53f3\u3002 \u6025\u6027\u814e\u640d\u50b7\u5e36\u4f86\u6c89\u91cd\u81e8\u5e8a\u8ca0\u64d4\uff0c\u76ee\u524d\u5c1a\u7121\u7372\u6279\u6cbb\u7642\u85e5\u7269\u3002\u8a72\u75c5\u6703\u5728\u6578\u5c0f\u6642\u5167\u9020\u6210\u814e\u529f\u80fd\u5feb\u901f\u8870\u9000\uff0c\u5927\u5e45\u589e\u52a0\u6162\u6027\u814e\u75c5\u53ca\u9060\u671f\u814e\u81df\u4f75\u767c\u75c7\u98a8\u96aa\u3002 \u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b72\u671f\u81e8\u5e8a\u8a66\u9a57 \u672c\u6b212\u671f\u8a66\u9a57\u9996\u8981\u9069\u61c9\u75c7\u70ba\u5fc3\u81df\u624b\u8853\u76f8\u95dc\u6025\u6027\u814e\u640d\u50b7(CS-AKI)\uff0c\u8a72\u4f75\u767c\u75c7\u5177\u5099\u53ef\u9810\u5224\u6027\uff0c\u591a\u898b\u65bc\u9ad4\u5916\u5faa\u74b0\u8207\u5fc3\u81df\u74e3\u819c\u624b\u8853\u3002\u8853\u4e2d\u9ad4\u5916\u5faa\u74b0\u6703\u5f15\u767c\u81df\u5668\u7f3a\u8840\u7f3a\u6c27\uff0c\u5f8c\u7e8c\u518d\u704c\u6ce8\u5fa9\u6c27\u74b0\u7bc0\u6975\u6613\u9020\u6210\u814e\u81df\u640d\u50b7\u3002 \u64ec\u5b9a\u958b\u5c55\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u70ba\u591a\u4e2d\u5fc3\u3001\u96d9\u76f2\u3001\u96a8\u6a5f\u3001\u5b89\u6170\u5291\u5c0d\u7167\u7814\u7a76\uff0c\u5165\u7d44\u7d04160\u540d\u5fc3\u81df\u8853\u5f8c\u6025\u6027\u814e\u640d\u50b7\u9ad8\u98a8\u96aa\u60a3\u8005\uff0c\u8a55\u4f30DMX-652\u7684\u5b89\u5168\u6027\u8207\u6709\u6548\u6027\uff0c\u4e3b\u8981\u81e8\u5e8a\u7d42\u9ede\u70ba\u8853\u5f8c7\u5929AKI\u767c\u751f\u7387\u3002\u81e8\u5e8a\u8a66\u9a57\u502b\u7406\u5be9\u6279\u8207\u81e8\u5e8a\u4e2d\u5fc3\u555f\u52d5\u9810\u8a08\u65bc2026\u5e74\u4e0b\u534a\u5e74\u5b8c\u6210\uff0c\u9996\u4f4d\u53d7\u8a66\u8005\u7d66\u85e5\u8a08\u5283\u57282027\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\uff0c2027\u5e74\u5167\u516c\u4f48\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u3002 \u5c08\u5229\u4fdd\u8b77 \u6839\u64da\u6536\u8cfc\u5354\u8b70\uff0cDMX-652\u7684\u7269\u8cea\u7d44\u5408\u7269\u5c08\u5229\u5bb6\u65cf(PCT\/EP2021\/064897)\u5c07\u8f49\u8b93\u7d66Dimerix\uff0c\u9810\u8a08\u6709\u6548\u671f\u81f32041\u5e74\uff0c\u540c\u6642\u9084\u5305\u62ec\u9032\u4e00\u6b65\u80cc\u666f\u5c08\u5229\u53ca\u81ea\u7531\u5be6\u65bd\u6240\u9700\u5c08\u5229\u7533\u8acb\uff08PCT\/GB2016\/050851\u3001PCT\/GB2019\/050608\uff09\u7684\u7368\u5bb6\u8a31\u53ef\u3002\u9664\u5c08\u5229\u4fdd\u8b77\u5916\uff0c\u82e5\u6210\u529f\u53d6\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\uff0cDMX-652\u7372\u6279\u4e0a\u5e02\u5f8c\u81f3\u5c11\u4eab\u67095\u5e74\u5e02\u5834\u7368\u4f54\u4fdd\u8b77\uff1b\u7f8e\u570b\u5e02\u5834\u7368\u4f54\u671f\u6700\u9577\u53ef\u5ef6\u9577\u81f37\u5e74\uff0c\u6b50\u6d32\u5730\u5340\u6700\u9577\u53ef\u905410\u5e74\u3002 \u5354\u8b70\u689d\u6b3e \u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cDimerix\u5c07\u64c1\u6709DMX-652\u7684\u7368\u5bb6\u6240\u6709\u6b0a\u4e26\u63a7\u5236\u5176\u958b\u767c\u3002\u76f8\u61c9\u5730\uff0cDimerix\u9700\u5728\u5354\u8b70\u7c3d\u7f72\u5f8c30\u65e5\u5167\u5411\u82f1\u570bMission Therapeutics\u652f\u4ed8500\u842c\u7f8e\u5143\u9996\u4ed8\u6b3e\uff1b\u9054\u6210\u9810\u8a2d\u81e8\u5e8a\u958b\u767c\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u9700\u652f\u4ed84700\u842c\u7f8e\u5143\u905e\u5ef6\u6536\u8cfc\u6b3e\u9805\uff1b\u7522\u54c1\u6210\u529f\u53d6\u5f97\u4e0a\u5e02\u8a31\u53ef\u5f8c\u652f\u4ed84000\u842c\u7f8e\u5143\uff1b\u7b2c\u4e8c\u500b\u9069\u61c9\u75c7\u7372\u6279\u652f\u4ed82500\u842c\u7f8e\u5143\uff1b\u9054\u6210\u6307\u5b9a\u92b7\u552e\u696d\u7e3e\u91cc\u7a0b\u7891\uff0c\u6700\u9ad8\u652f\u4ed81.75\u5104\u7f8e\u5143\u696d\u7e3e\u5206\u6210\u3002\u82e5\u7531Dimerix\u81ea\u884c\u5546\u696d\u5316\u92b7\u552e\uff0cDimerix\u9700\u6309\u5168\u7403\u6de8\u92b7\u552e\u984d\u76848%\u201310%\u652f\u4ed8\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff1b\u82e5\u6388\u6b0a\u7b2c\u4e09\u65b9\u5206\u8a31\u53ef\u65b9\u92b7\u552e\uff0c\u5247\u6309\u6de8\u92b7\u552e\u984d\u76842.5%\u20135%\u652f\u4ed8\u3002\u6240\u6709\u5408\u540c\u8ca1\u52d9\u689d\u6b3e\u5747\u4ee5\u7f8e\u5143\u8a08\u50f9\u3002\u82e5Dimerix\u9078\u64c7\u4e0d\u7e7c\u7e8c\u958b\u767c\uff0cMission\u64c1\u6709\u512a\u5148\u8ac7\u5224\u6b0a\u6536\u56de\u6240\u6536\u8cfc\u8cc7\u7522\u3002 \u6f5b\u5728\u5229\u597d\u50ac\u5316\u4e8b\u4ef6 Dimerix\u5728\u63a8\u9032DMX-200\u7684\u95dc\u9375\u6027ACTION3 3\u671f\u8a66\u9a57\u65b9\u9762\u82e5\u53d6\u5f97\u7a4d\u6975\u6210\u679c\uff0c\u5c07\u6210\u70ba\u91cd\u5927\u50f9\u503c\u91cb\u653e\u7bc0\u9ede\uff1b\u8207\u6b64\u540c\u6642\uff0cDMX-652\u63a8\u9032\u81f32\u671f\u81e8\u5e8a\u5c07\u9032\u4e00\u6b65\u5f37\u5316\u8a72\u516c\u53f8\u589e\u9577\u6f5b\u529b\u3002DMX-652\u7814\u767c\u53d6\u5f97\u9032\u5c55\u8207\u7a4d\u6975\u81e8\u5e8a\u6578\u64da\uff0c\u6709\u671b\u5927\u5e45\u63d0\u5347\u80a1\u6771\u50f9\u503c\u3001\u8c50\u5bccDimerix\u7684\u81e8\u5e8a\u7ba1\u7dda\uff0c\u70ba\u6fb3\u4ea4\u6240\u6295\u8cc7\u8005\u63d0\u4f9b\u591a\u500b\u77ed\u671f\u3001\u4e2d\u671f\u5229\u597d\u50ac\u5316\u3002 \u8cc7\u91d1 Dimerix\u78ba\u8a8d\uff0c\u516c\u53f8\u8cc7\u91d1\u8db3\u4ee5\u652f\u6301DMX-200\u7684ACTION3 3\u671f\u8a66\u9a57\u5b8c\u6210\u53caDMX-652\u76842\u671f\u81e8\u5e8a\u8a66\u9a57\u555f\u52d5\uff0c\u8cc7\u91d1\u4f86\u6e90\u5305\u62ec\uff1a \u73fe\u6709\u73fe\u91d1\u5132\u5099\uff1b \u9810\u8a08\u5f9eEverest Medicines\u6536\u5230\u7684\u7d041400\u842c\u6fb3\u5143\u7684\u5927\u4e2d\u83ef\u5340\u3001\u97d3\u570b\u53ca\u6771\u5357\u4e9e\u5546\u696d\u6b0a\u5229\u9996\u4ed8\u6b3e\uff1b\u4ee5\u53ca \u4e00\u4efd\u5177\u6709\u7d04\u675f\u529b\u7684\u8cb8\u6b3e\u5354\u8b70\uff0c\u984d\u5ea61000\u842c\u6fb3\u5143\uff0c\u63d0\u6b3e\u6642\u9ede\u7531\u516c\u53f8\u81ea\u4e3b\u6309\u9700\u6c7a\u5b9a\u3002 \u516c\u53f8\u6b63\u5728\u6d3d\u8ac7\u53e6\u4e00\u7b46\u6700\u9ad84000\u842c\u6fb3\u5143\u975e\u7a00\u91cb\u6027\u88dc\u5145\u878d\u8cc7\uff0c\u878d\u8cc7\u689d\u6b3e\u9810\u8a08\u8207\u73fe\u6709\u8cb8\u6b3e\u6846\u67b6\u57fa\u672c\u4e00\u81f4\u3002\u65b0\u589e\u8cc7\u91d1\u5c07\u5ef6\u9577\u8a72\u516c\u53f8\u73fe\u91d1\u4f7f\u7528\u9031\u671f\uff0c\u8db3\u984d\u8986\u84cbDMX-200 ACTION3 3\u671f\u81e8\u5e8a\u8a66\u9a57\u5168\u90e8\u652f\u51fa\uff0c\u540c\u6642\u652f\u6490Dimerix\u642d\u5efa\u53ef\u6301\u7e8c\u7684\u7f55\u898b\u75c5\u3001\u814e\u75c5\u7ba1\u7dda\u7814\u767c\u9ad4\u7cfb\u3002,\u66f4\u591a\u878d\u8cc7\u5354\u8b70\u8a73\u60c5\uff0c\u8acb\u53c3\u898b2026\u5e747\u670817\u65e5\u6fb3\u4ea4\u6240\u516c\u544a\u3002 \u7d93Dimerix\u8463\u4e8b\u6703\u6388\u6b0a\u5411\u6fb3\u4ea4\u6240\u63d0\u4ea4\u3002 \u66f4\u591a\u8a73\u60c5\uff0c\u8acb\u8a2a\u554f\u516c\u53f8\u7db2\u7ad9\uff1awww.dimerix.com \u5728LinkedIn\u548cX\u5e73\u53f0\u4e0a\u95dc\u6ce8Dimerix\u8cec\u865f \u95dc\u65bcDimerix Dimerix Limited (ASX: DXB)\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u91dd\u5c0d\u5b58\u5728\u5927\u91cf\u672a\u6eff\u8db3\u91ab\u7642\u9700\u6c42\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002\u516c\u53f8\u7684\u6838\u5fc3\u9805\u76eeDMX-200\u76ee\u524d\u6b63\u8655\u65bc\u5c40\u7076\u7bc0\u6bb5\u6027\u814e\u5c0f\u7403\u786c\u5316\u75c7(FSGS)\u76843\u671f\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0cFSGS\u662f\u4e00\u7a2e\u56b4\u91cd\u4e14\u5371\u53ca\u751f\u547d\u7684\u7f55\u898b\u814e\u81df\u75be\u75c5\uff0c\u6cbb\u7642\u624b\u6bb5\u6709\u9650\u3002\u6b64\u5916\uff0cDimerix\u6b63\u5728\u63a8\u9032\u4e00\u500b\u6025\u6027\u814e\u640d\u50b7(AKI) 2\u671f\u9805\u76ee\uff0c\u9032\u4e00\u6b65\u5b8c\u5584\u9ad8\u9700\u6c42\u814e\u75c5\u9069\u61c9\u75c7\u4f48\u5c40\u3002Dimerix\u73fe\u5df2\u8207\u4e94\u5bb6\u5546\u696d\u5408\u4f5c\u5925\u4f34\u5efa\u7acb\u5168\u7403\u958b\u767c\u8207\u5546\u696d\u5316\u5408\u4f5c\u7db2\u7d61\uff0c\u81f4\u529b\u65bc\u64f4\u5927\u85e5\u7269\u53ef\u53ca\u7bc4\u570d\uff0c\u70ba\u5168\u7403\u76e1\u53ef\u80fd\u591a\u7684\u60a3\u8005\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u540c\u6642\u70ba\u80a1\u6771\u5275\u9020\u9577\u671f\u50f9\u503c\u3002 \u95dc\u65bcMission Therapeutics Mission Therapeutics\u662f\u767c\u73fe\u548c\u958b\u767c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u6e05\u9664\u3001\u6539\u5584\u7d30\u80de\u5065\u5eb7\u8207\u529f\u80fd\u7684\u65b0\u578b\u7642\u6cd5\u7684\u5168\u7403\u9818\u5c0e\u8005\u3002Mission\u76ee\u524d\u6b63\u5728\u958b\u767c\u5c0f\u5206\u5b50\u85e5\u7269MTX325\uff08\u9776\u5411\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff09\uff0c\u8a72\u85e5\u7269\u901a\u904e\u6291\u5236\u7dda\u7c92\u9ad4DUB\u9176USP30\uff0c\u4fc3\u9032\u529f\u80fd\u5931\u8abf\u7dda\u7c92\u9ad4\u7684\u6e05\u9664\uff0c\u5f9e\u800c\u6539\u5584\u6574\u9ad4\u7d30\u80de\u5065\u5eb7\u3002 Mission\u7372\u5f97\u4e86\u5305\u62ecPfizer Venture Investments\u3001Sofinnova Partners\u3001Roche Venture Fund\u3001SR One\u3001IP Group\u548cRosetta Capital\u5728\u5167\u7684\u85cd\u7c4c\u6295\u8cc7\u65b9\u7684\u652f\u6301\u3002 \u95dc\u65bcDMX-200\u5728FSGS\u4e2d\u7684\u61c9\u7528 DMX-200\u662f\u4e00\u7a2e\u8da8\u5316\u56e0\u5b50\u53d7\u9ad4(CCR2)\u62ee\u6297\u5291\uff0c\u7528\u65bc\u5df2\u63a5\u53d7\u8840\u7ba1\u7dca\u5f35\u7d20II 1\u578b\u53d7\u9ad4(AT1R)\u963b\u6eef\u5291\uff08\u9ad8\u8840\u58d3\u548c\u814e\u81df\u75be\u75c5\u7684\u6a19\u6e96\u6cbb\u7642\u85e5\u7269\uff09\u6cbb\u7642\u7684\u60a3\u8005\u3002DMX-200\u5728\u5168\u7403\u591a\u570b\u64c1\u6709\u6388\u6b0a\u5c08\u5229\uff0c\u4fdd\u8b77\u671f\u81f32032\u5e74\uff1b\u8a72\u85e5\u591a\u9805\u5168\u7403\u5c08\u5229\u7533\u8acb\u6709\u671b\u5c07\u4fdd\u8b77\u671f\u9650\u5ef6\u9577\u81f32042\u5e74\uff0c\u4e14\u5df2\u5728\u7f8e\u570b\u3001\u6b50\u6d32\u3001\u82f1\u570b\u3001\u65e5\u672c\u7372\u5f97\u5b64\u5152\u85e5\u8cc7\u683c\u8a8d\u5b9a\u3002 FSGS\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u56b4\u91cd\u814e\u81df\u75be\u75c5\uff0c\u5176\u7279\u5fb5\u70ba\u814e\u5c0f\u7403\uff08\u814e\u81df\u7684\u904e\u6ffe\u55ae\u4f4d\uff09\u5c40\u90e8\u9032\u884c\u6027\u7622\u75d5\u5f62\u6210\uff08\u786c\u5316\uff09\u3002\u9019\u7a2e\u7622\u75d5\u5f62\u6210\u6703\u5f15\u767c\u86cb\u767d\u5c3f\u3001\u814e\u529f\u80fd\u9032\u884c\u6027\u55aa\u5931\uff0c\u4e26\u5e38\u767c\u5c55\u70ba\u7d42\u672b\u671f\u814e\u75c5\u3002\u8d8a\u4f86\u8d8a\u591a\u7814\u7a76\u8868\u660eFSGS\u4f34\u96a8\u708e\u75c7\u53cd\u61c9\uff0c\u55ae\u6838\u7d30\u80de\u8207\u5de8\u566c\u7d30\u80de\u6d3b\u5316\u6703\u52a0\u5287\u814e\u5c0f\u7403\u640d\u50b7\u3002\u5728\u7f8e\u570b\uff0c\u4f30\u8a08\u6709\u8d85\u904e4\u842c\u4eba\uff08\u5305\u62ec\u6210\u4eba\u548c\u5152\u7ae5\uff09\u60a3\u6709FSGS\u3002\u76ee\u524d\u7f8e\u570b\u5c1a\u7121\u5c08\u9580\u7372\u6279\u6cbb\u7642FSGS\u7684\u85e5\u7269\uff0c\u81e8\u5e8a\u50c5\u4f9d\u9760\u975e\u7279\u7570\u6027\u514d\u75ab\u6291\u5236\u5291\u8207\u652f\u6301\u6027\u6cbb\u7642\u63a7\u5236\u75c5\u60c5\u3002\u5c0d\u65bc\u9032\u5c55\u578b\u3001\u85e5\u7269\u62b5\u6297\u578bFSGS\u60a3\u8005\uff0c\u81ea\u78ba\u8a3a\u81f3\u7d42\u672b\u671f\u814e\u75c5\u5e73\u5747\u75c5\u7a0b\u50c5\u4e94\u5e74\uff1b\u5373\u4fbf\u63a5\u53d7\u814e\u79fb\u690d\uff0c\u8a72\u75c5\u5fa9\u767c\u7387\u4e5f\u9ad8\u905460%\uff0c\u5e02\u5834\u4e9f\u9700\u53ef\u6539\u8b8a\u75c5\u7a0b\u7684\u5168\u65b0\u6cbb\u7642\u65b9\u6848\u3002 Dimerix\u524d\u77bb\u6027\u9673\u8ff0 \u672c\u65b0\u805e\u7a3f\u5305\u542b\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u76f8\u95dc\u5167\u5bb9\u5b58\u5728\u98a8\u96aa\u8207\u4e0d\u78ba\u5b9a\u6027\u3002\u5118\u7ba1\u7ba1\u7406\u5c64\u8a8d\u70ba\u672c\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u53cd\u6620\u7684\u9810\u671f\u5728\u76ee\u524d\u662f\u5408\u7406\u7684\uff0c\u4f46Dimerix\u4e0d\u80fd\u4fdd\u8b49\u9019\u4e9b\u9810\u671f\u80fd\u5920\u514c\u73fe\u3002\u7279\u6b64\u63d0\u9192\u8b80\u8005\u5207\u52ff\u904e\u5ea6\u4f9d\u8cf4\u524d\u77bb\u6027\u9673\u8ff0\u3002\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u9810\u671f\u5b58\u5728\u91cd\u5927\u51fa\u5165\u3002\u539f\u56e0\u53ef\u80fd\u5305\u62ec\uff1a\u85e5\u7269\u7814\u767c\u8207\u751f\u7522\u98a8\u96aa\u3001\u76e3\u7ba1\u6d41\u7a0b\u56fa\u6709\u7684\u98a8\u96aa\u3001\u81e8\u5e8a\u8a66\u9a57\u5ef6\u671f\u3001\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u3001\u5408\u540c\u98a8\u96aa\u3001\u5c08\u5229\u4fdd\u8b77\u76f8\u95dc\u98a8\u96aa\u3001\u5f8c\u7e8c\u8cc7\u91d1\u9700\u6c42\uff0c\u6216\u5176\u4ed6\u4e00\u822c\u98a8\u96aa\u6216\u56e0\u7d20\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bcDimerix Limited\u6700\u65b0\u5e74\u5ea6\u5831\u544a\u4e2d\u5217\u51fa\u7684\u98a8\u96aa\u56e0\u7d20\u3002 \u53c3\u8003\u6587\u737b \u00a0Internal market analysis based on meta-analysis of 21 market reports (2026) ; Includes China and Japan markets, label expansion into sepsis-associated AKI (SA-AKI) and contrast-associated AKI \u00a0Ostermann M, Lumlertgul N, Jeong R, et al. Acute kidney injury, (2025) Lancet 405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7 \u00a0\u00a0Subject to recruitment \u00a0\u00a0Funding subject to a definitive agreement(s) being executed (which is expected to include customary conditions precedent) \u00a0\u00a0Based on current anticipated spend and activities; should activities or spend change, this could materially impact the cash runway of the Company \u00a0\u00a0ASX releases: 14 December 2015, 21 November 2018, 07 June 2021, 30 September 2025 \u00a0\u00a0Nephcure FSGS Facts (https:\/\/nephcure.org\/) \u00a0\u00a0Front. Immunol., (July 2019) |\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.01669 \u00a0","breadcrumb":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pingtungtimes.com.tw\/?p=454376"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#primaryimage","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":"3000","height":"1990"},{"@type":"BreadcrumbList","@id":"https:\/\/pingtungtimes.com.tw\/?p=454376#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/pingtungtimes.com.tw\/"},{"@type":"ListItem","position":2,"name":"Dimerix\u6536\u8cfc\u4e00\u6b3e\u5df2\u5177\u50992\u671f\u81e8\u5e8a\u555f\u52d5\u689d\u4ef6\u7684\u6025\u6027\u814e\u640d\u50b7\u5019\u9078\u85e5\u7269\uff0c\u64f4\u5145\u7814\u767c\u7ba1\u7dda"}]},{"@type":"WebSite","@id":"https:\/\/pingtungtimes.com.tw\/#website","url":"https:\/\/pingtungtimes.com.tw\/","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4","publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pingtungtimes.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/pingtungtimes.com.tw\/#organization","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","url":"https:\/\/pingtungtimes.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":150,"height":150,"caption":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pingtungnews"]},{"@type":"Person","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3","name":"\u7f8e\u901a\u793e","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","caption":"\u7f8e\u901a\u793e"},"url":"https:\/\/pingtungtimes.com.tw\/?author=16"}]}},"_links":{"self":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/454376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=454376"}],"version-history":[{"count":0,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/454376\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/media\/199219"}],"wp:attachment":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=454376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=454376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=454376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}